Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nolan

Showing results (61-70 of 1,252) with videos related to

Pageof 126
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 13, 2003
Isoniazid for latent tuberculosis infection: approaching 40 and reaching its primeCharles M Nolan
American Journal of Public Health|December 1, 1990
Incorporation of pyrazinamide into community-wide treatment of tuberculosisC M Nolan
The Medical Journal of Australia|September 30, 2020
"No jab, no pay" pays offTerence M Nolan
The Medical Journal of Australia|January 23, 1982
School blood lead levelsB M Nolan
The Journal of the Arkansas Medical Society|April 1, 1976
Editorial: Prevention of hepatitis B: A favorable turn of eventsC M Nolan
The Journal of Infectious Diseases|September 18, 1997
Nosocomial multidrug-resistant tuberculosis--global spread of the third epidemicC M Nolan
Pharmacogenomics|March 21, 2001
Generation of mouse mutants as a tool for functional genomicsP M Nolan
American Journal of Infection Control|February 1, 1992
Human immunodeficiency syndrome-associated tuberculosis: a review with an emphasis on infection control issuesC M Nolan
The New England Journal of Medicine|September 9, 1993
Reinfection with multidrug-resistant tuberculosisC M Nolan
Annals of Internal Medicine|June 1, 1994
Tuberculosis in health care professionals: assessing and accepting the riskC M Nolan
Pageof 126

Showing results (61-70 of 1,252) with videos related to

Sort By:
Pageof 126
American Journal of Respiratory and Critical Care Medicine|August 13, 2003
Isoniazid for latent tuberculosis infection: approaching 40 and reaching its primeCharles M Nolan
American Journal of Public Health|December 1, 1990
Incorporation of pyrazinamide into community-wide treatment of tuberculosisC M Nolan
The Medical Journal of Australia|September 30, 2020
"No jab, no pay" pays offTerence M Nolan
The Medical Journal of Australia|January 23, 1982
School blood lead levelsB M Nolan
The Journal of the Arkansas Medical Society|April 1, 1976
Editorial: Prevention of hepatitis B: A favorable turn of eventsC M Nolan
The Journal of Infectious Diseases|September 18, 1997
Nosocomial multidrug-resistant tuberculosis--global spread of the third epidemicC M Nolan
Pharmacogenomics|March 21, 2001
Generation of mouse mutants as a tool for functional genomicsP M Nolan
American Journal of Infection Control|February 1, 1992
Human immunodeficiency syndrome-associated tuberculosis: a review with an emphasis on infection control issuesC M Nolan
The New England Journal of Medicine|September 9, 1993
Reinfection with multidrug-resistant tuberculosisC M Nolan
Annals of Internal Medicine|June 1, 1994
Tuberculosis in health care professionals: assessing and accepting the riskC M Nolan
Pageof 126